We provide our members with support to do cutting-edge research through:
- Introductions to collaborators from our home institutions and the wider network of HIV-leading investigators
- Identifying opportunities for funding through NIH or other funding bodies
- Providing strategies for competitive grant applications and feedback from senior investigators on grant drafts
- Assistance with organizing multi-investigator grant submissions
- Offering pilot grant funding to jumpstart or supplement your research endeavors
Submitting a grant?
Our Texas D-CFAR leadership can do a “mock review” to help you prepare a competitive grant application.
The mock review process helped me get unique perspectives on my grant submission, in-depth actionable feedback, and the special opportunity to ask questions and brainstorm ways to address any potential concerns with my submission.
For funding opportunities visit the following sites:
- New NOSI for EHE efforts
- NIH Grants & Funding
- Grants.gov
- Pilot Grant RFA Jan 2024
- Pilot Grant Instructions Jan 2024
Notice of Extension of NOT-HL-20-761 "Notice of Special Interest (NOSI): Pulmonary Complications of Hematopoietic Stem Cell Transplantation in Childhood". Expires Jan. 1, 2025
Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed). Expires July 2, 2024
Notice of Special Interest (NOSI): Administrative Supplements for Research on Womens Health in the IDeA States. Expires Oct. 18, 2024
Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required). Expires July 2, 2024
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed). Expires July 2, 2024
Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed). Expires July 2, 2024
NIMH FOAs
NOT-MH-21-105: Notice of Special Interest (NOSI): Advancing Health Communication Research on HIV Prevention, Treatment, and Cure
NOT-MH-22-095: Notice of Special Interest (NOSI): NIMH Priorities on Research on Aggression and Violence Against Others
Co-Sponsored FOAs
NOT-AI-21-054: Notice of Special Interest (NOSI): Harnessing Big Data to Halt HIV
NOT-AI-21-057: Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide
NOT-CA-22-037: Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research
NOT-DA-21-060: Notice of Special Interest (NOSI): Reducing Stigma Related to Drug Use in Human Service Settings
NOT-OD-21-100: Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health
NOT-AI-21-011: Notice of Special Interest (NOSI): Secondary Analysis of Existing Datasets for Advancing Immune-mediated and Infectious Disease Research
NOT-CA-22-037: Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research
NOT-MH-22-095: Notice of Special Interest: NIMH Priorities on Aggression and Violence Against Others
PAR-21-068: Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
PAR-21-297: Novel Systemic Options for Young Adults under the tab PA-Joint; Multipurpose Prevention Technology
PAR-21-297: Multipurpose Prevention Technology: Novel Systemic Options for Young Adults
